A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Wedbush conference too good on Wednesday.
2.76... ouch!
Your persistence on YMB and SA make me believe you have a real dog in this fight. Sorry to hear that...
Similar, on the MF articles we had discussed the phases, market cap, vs funding needs and it appeared you had sold and was monitoring until recently on the SA articles. Maybe the Wedbush Conference will help since it was originally unscheduled and "inserted" items are usually consequential. I'm afraid, however, it could have also been inserted to help the stock price as PPHM continued selling more of thier authorized shares into the opne market. Unfortunately, with the 500% run-up there were a lot of shares "in the money" and investors/traders are more protective of gains due to the volitility of late. Best wishes, I closed my CAPS pick and it was my only "skin in the game" and I would gladly shed caps points for successful drugs.
I have real money in it and bought yesterday a lot. This one will remain volatile until Sept 7 and I can improve my position. Yesterday was a perfect day to do that - obviously one needs good nerves.
All the short attacks make me very optimistic btw. Why would anyone push negative articles before Sept. 7? If the company is sooooo bad that would not be necessary. What I think is that the shorts are getting desperate.
@PoolSkunk: YMB? SA yes, but what is YMB. Stocktwitz?
YMB, Yahoo Message Board
I never noticed you there as the board is a wasteland, generally with people shouting over each other. I check it occasionally when researching a stock new to me as a few of the "quieter" boards do have people knowledgeable about some upcoming catalysts you may not find noted on the newsfeeds.
Good luck, personally while the timing/frequency of the MF articles may be "suspect", the authors quoted are simply looking at an equity with a 500% run-up and hence their timing. I suspect the run-up also caught some people making the short play too early and did generate some short articles, especially on SA. Shorts, are often wrong, and they pile up way to dense on some stocks. Overtime, shorts are right more often than they are wrong, or they wouldn't play the game.
I sold some of my shares at $5 right now. All my shares are on the house. Still long :)